These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18776916)

  • 21. Pharmacology of erenumab in human isolated coronary and meningeal arteries: Additional effect of gepants on top of a maximum effect of erenumab.
    de Vries T; Rubio-Beltrán E; van den Bogaerdt A; Dammers R; Danser AHJ; Snellman J; Bussiere J; MaassenVanDenBrink A
    Br J Pharmacol; 2024 Jun; 181(12):1720-1733. PubMed ID: 38320397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve.
    Escott KJ; Brain SD
    Br J Pharmacol; 1993 Oct; 110(2):772-6. PubMed ID: 8242250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
    Tringali G; Navarra P
    Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery - potential antimigraine efficacy.
    Labastida-Ramírez A; Rubio-Beltrán E; Haanes KA; de Vries R; Dammers R; Bogers AJJC; van den Bogaerdt A; Daugherty BL; Danser AHJ; Villalón CM; MaassenVanDenBrink A
    J Headache Pain; 2019 May; 20(1):47. PubMed ID: 31053059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.
    Ohlsson L; Haanes KA; Kronvall E; Xu C; Snellman J; Edvinsson L
    Cephalalgia; 2019 Dec; 39(14):1745-1752. PubMed ID: 31366221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells.
    Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I
    Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody.
    Kielbasa W; Helton DL
    Cephalalgia; 2019 Sep; 39(10):1284-1297. PubMed ID: 30917684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CGRP blockers in migraine therapy: where do they act?
    Edvinsson L
    Br J Pharmacol; 2008 Dec; 155(7):967-9. PubMed ID: 18776915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class.
    Arca K; Reynolds J; Sands KA; Shiue HJ
    Ann Pharmacother; 2020 Aug; 54(8):795-803. PubMed ID: 32019317
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
    Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
    Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
    Bigal ME; Walter S
    CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymoquinone Inhibits Neurogenic Inflammation Underlying Migraine Through Modulation of Calcitonin Gene-Related Peptide Release and Stabilization of Meningeal Mast Cells in Glyceryltrinitrate-Induced Migraine Model in Rats.
    Kilinc E; Tore F; Dagistan Y; Bugdayci G
    Inflammation; 2020 Feb; 43(1):264-273. PubMed ID: 31707574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
    Haanes KA; Labastida-Ramírez A; Blixt FW; Rubio-Beltrán E; Dirven CM; Danser AH; Edvinsson L; MaassenVanDenBrink A
    Cephalalgia; 2019 Oct; 39(11):1421-1434. PubMed ID: 31104506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
    Melo-Carrillo A; Strassman AM; Nir RR; Schain AJ; Noseda R; Stratton J; Burstein R
    J Neurosci; 2017 Nov; 37(44):10587-10596. PubMed ID: 28972120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.
    Aiyar N; Daines RA; Disa J; Chambers PA; Sauermelch CF; Quiniou M; Khandoudi N; Gout B; Douglas SA; Willette RN
    J Pharmacol Exp Ther; 2001 Mar; 296(3):768-75. PubMed ID: 11181905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody.
    Melo-Carrillo A; Noseda R; Nir RR; Schain AJ; Stratton J; Strassman AM; Burstein R
    J Neurosci; 2017 Jul; 37(30):7149-7163. PubMed ID: 28642283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigens and Antibodies in Disease With Specifics About CGRP Immunology.
    Taylor FR
    Headache; 2018 Nov; 58 Suppl 3():230-237. PubMed ID: 30187471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation.
    Akerman S; Kaube H; Goadsby PJ
    Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.